Basic Information
RNALocate ID: | RLID:11002546 |
RNA Symbol: | hsa-miR-381-3p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-381-3p |
RNA ID: | miRBase:MIMAT0000736 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 25242326 |
Tissue/Cell Line: | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells |
Method: | Next-generation RNA sequencing |
Description: | Although the miRNA distribution in exosomal fractions is clearly influenced by cellular miRNA abundance, we identified a subset of miRNAs that were discordantly distributed between cells and exosomes (false discovery rate [FDR] < 0.05; Tables S1B and S1C). |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:11002543 | Exosome | Serum | 18589210 |
RLID:11002544 | Exosome | Brain tissue | 23382797 |
RLID:11002545 | Exosome | Plasma | 23663360 |
RLID:11002547 | Microvesicle | Cerebrospinal fluid | 24797360 |
RLID-D:11000125 | Exosome | Blood|Endothelial cells | |
RLID-D:11000424 | Microvesicle | Blood|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-381-3p | Oral squamous cell carcinoma | MNDR-E-MI-47037 |
MNDR | hsa-miR-381-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-47038 |
MNDR | hsa-miR-381-3p | Ovarian clear cell carcinoma | MNDR-E-MI-47039 |
MNDR | hsa-miR-381-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-47040 |
MNDR | hsa-miR-381-3p | Autism spectrum disorder | MNDR-E-MI-47041 |
MNDR | hsa-miR-381-3p | Lymphoma | MNDR-E-MI-47042 |
MNDR | hsa-miR-381-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-47043 |
MNDR | hsa-miR-381-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-47044 |
MNDR | hsa-miR-381-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-47045 |
MNDR | hsa-miR-381-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-47046 |
MNDR | hsa-miR-381-3p | Her2-receptor positive breast cancer | MNDR-E-MI-47047 |
MNDR | hsa-miR-381-3p | Breast cancer luminal | MNDR-E-MI-47048 |
MNDR | hsa-miR-381-3p | Lupus nephritis | MNDR-E-MI-47049 |
MNDR | hsa-miR-381-3p | Dermatomyositis | MNDR-E-MI-47050 |
MNDR | hsa-miR-381-3p | Prostate cancer | MNDR-E-MI-47051 |
MNDR | hsa-miR-381-3p | Gastric cancer | MNDR-E-MI-47052 |
MNDR | hsa-miR-381-3p | Alzheimer disease | MNDR-E-MI-47053 |
MNDR | hsa-miR-381-3p | Bladder cancer | MNDR-E-MI-47054 |
MNDR | hsa-miR-381-3p | Esophageal carcinoma | MNDR-E-MI-47055 |
MNDR | hsa-miR-381-3p | Dysautonomia familial | MNDR-E-MI-47056 |
MNDR | hsa-miR-381-3p | Myotonic dystrophy | MNDR-E-MI-47057 |
MNDR | hsa-miR-381-3p | Muscular dystrophy duchenne | MNDR-E-MI-47058 |
MNDR | hsa-miR-381-3p | Huntington disease | MNDR-E-MI-47059 |
MNDR | hsa-miR-381-3p | Cardiovascular disease | MNDR-E-MI-47060 |
MNDR | hsa-miR-381-3p | Lung cancer | MNDR-E-MI-47061 |
MNDR | hsa-miR-381-3p | Fragile x syndrome | MNDR-E-MI-47062 |
MNDR | hsa-miR-381-3p | Parkinson disease | MNDR-E-MI-47063 |
MNDR | hsa-miR-381-3p | Major depressive disorder | MNDR-E-MI-47064 |
MNDR | hsa-miR-381-3p | Basal-like breast cancer | MNDR-E-MI-47065 |
MNDR | hsa-miR-381-3p | Thyroid cancer | MNDR-E-MI-47066 |
MNDR | hsa-miR-381-3p | Pituitary neoplasms | MNDR-E-MI-47067 |
MNDR | hsa-miR-381-3p | Pancreatic cancer | MNDR-E-MI-47068 |
MNDR | hsa-miR-381-3p | Melanoma | MNDR-E-MI-47069 |
MNDR | hsa-miR-381-3p | Rectum adenocarcinoma | MNDR-E-MI-47070 |
MNDR | hsa-miR-381-3p | Nephroblastoma | MNDR-E-MI-47071 |
MNDR | hsa-miR-381-3p | Colon cancer | MNDR-E-MI-47072 |
MNDR | hsa-miR-381-3p | Familial ovarian cancer | MNDR-E-MI-47073 |
MNDR | hsa-miR-381-3p | Acromegaly | MNDR-E-MI-47074 |
MNDR | hsa-miR-381-3p | Prostate adenocarcinoma | MNDR-E-MI-47075 |
MNDR | hsa-miR-381-3p | Pulmonary tuberculosis | MNDR-E-MI-47076 |
MNDR | hsa-miR-381-3p | Carcinoma ductal breast | MNDR-E-MI-47077 |
MNDR | hsa-miR-381-3p | Glioblastoma | MNDR-E-MI-47078 |
MNDR | hsa-miR-381-3p | Glioma | MNDR-E-MI-47079 |
MNDR | hsa-miR-381-3p | Nemaline myopathy | MNDR-E-MI-47080 |
MNDR | hsa-miR-381-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-47081 |
MNDR | hsa-miR-381-3p | Osteosarcoma | MNDR-E-MI-47082 |
MNDR | hsa-miR-381-3p | Liposarcoma | MNDR-E-MI-47083 |
MNDR | hsa-miR-381-3p | Inclusion body myositis | MNDR-E-MI-47084 |
MNDR | hsa-miR-381-3p | Breast carcinoma | MNDR-E-MI-47085 |
MNDR | hsa-miR-381-3p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-47086 |
MNDR | hsa-miR-381-3p | Uterine cancer | MNDR-E-MI-47087 |
MNDR | hsa-miR-381-3p | Gastric adenocarcinoma | MNDR-E-MI-47088 |
MNDR | hsa-miR-381-3p | Cervical squamous cell carcinoma | MNDR-E-MI-47089 |
MNDR | hsa-miR-381-3p | Bone-invasive pituitary adenoma | MNDR-E-MI-47090 |
MNDR | hsa-miR-381-3p | Lung squamous cell carcinoma | MNDR-E-MI-47091 |
MNDR | hsa-miR-381-3p | Non-small cell lung adenocarcinoma | MNDR-E-MI-47092 |
MNDR | hsa-miR-381-3p | Lung adenocarcinoma | MNDR-E-MI-47093 |
MNDR | hsa-miR-381-3p | Adrenocortical carcinoma | MNDR-E-MI-47094 |
MNDR | hsa-miR-381-3p | Thyroid carcinoma | MNDR-E-MI-47095 |
MNDR | hsa-miR-381-3p | Papillary thyroid carcinoma | MNDR-E-MI-47096 |
MNDR | hsa-miR-381-3p | Ovarian carcinoma | MNDR-E-MI-47097 |
MNDR | hsa-miR-381-3p | Bladder urothelial carcinoma | MNDR-E-MI-47098 |
MNDR | hsa-miR-381-3p | Carcinoma renal cell | MNDR-E-MI-47099 |
MNDR | hsa-miR-381-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-47100 |
MNDR | hsa-miR-381-3p | Renal clear cell carcinoma | MNDR-E-MI-47101 |
MNDR | hsa-miR-381-3p | Cholangiocarcinoma | MNDR-E-MI-47102 |
MNDR | hsa-miR-381-3p | Esophageal cancer | MNDR-E-MI-47103 |
MNDR | hsa-miR-381-3p | Lung small cell carcinoma | MNDR-E-MI-47104 |
MNDR | hsa-miR-381-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-47105 |
MNDR | hsa-miR-381-3p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-47106 |
MNDR | hsa-miR-381-3p | Breast invasive carcinoma | MNDR-E-MI-47107 |
MNDR | hsa-miR-381-3p | Hepatocellular carcinoma | MNDR-E-MI-47108 |
MNDR | hsa-miR-381-3p | Familiar ovarian carcinoma | MNDR-E-MI-47109 |
MNDR | hsa-miR-381-3p | Rheumatoid arthritis | MNDR-E-MI-47110 |
MNDR | hsa-miR-381-3p | Barrett's adenocarcinoma | MNDR-E-MI-47111 |
MNDR | hsa-miR-381-3p | Chronic fatigue syndrome | MNDR-E-MI-47112 |
MNDR | hsa-miR-381-3p | Tonsil cancer | MNDR-E-MI-47113 |
MNDR | hsa-miR-381-3p | Psoriasis | MNDR-E-MI-47114 |
MNDR | hsa-miR-381-3p | Colorectal cancer | MNDR-E-MI-47115 |
MNDR | hsa-miR-381-3p | Stroke lacunar | MNDR-E-MI-47116 |
MNDR | hsa-miR-381-3p | Barrett's carcinogenesis | MNDR-E-MI-47117 |
MNDR | hsa-miR-381-3p | Breast cancer her3+ negative | MNDR-E-MI-47118 |
MNDR | hsa-miR-381-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-47119 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ANO1 | Homo sapiens | RR00082904 |
TOP